Abstract
Guanylyl cyclase A (GC-A), the receptor for atrial and B-type natriuretic peptides, is implicated in the regulation of blood pressure and cardiac growth. We used design-based stereological methods to examine the effect of GC-A inactivation on cardiomyocyte volume, number and subcellular composition in postnatal mice at day P2. In mice with global, systemic GC-A deletion, the cardiomyocyte number was significantly increased, demonstrating that hyperplasia is the main cause for the increase in ventricle weight in these early postnatal animals. In contrast, conditional, cardiomyocyte-restricted inactivation of GC-A had no significant effect on ventricle weight or cardiomyocyte number. The mean volume of cardiomyocytes and the myocyte-related volumes of the four major cell organelles (myofibrils, mitochondria, nuclei and sarcoplasm) were similar between genotypes. Taken together, systemic GC-A deficiency induces cardiac enlargement based on a higher number of normally composed and sized cardiomyocytes early after birth, whereas cardiomyocyte-specific GC-A abrogation is not sufficient to induce cardiac enlargement and has no effect on number, size and composition of cardiomyocytes. We conclude that postnatal cardiac hyperplasia in mice with global GC-A inactivation is provoked by systemic alterations, e.g., arterial hypertension. Direct GC-A-mediated effects in cardiomyocytes seem not to be involved in the regulation of myocyte proliferation at this early stage.
Similar content being viewed by others
References
Anand-Srivastava MB, Trachte GJ (1993) Atrial natriuretic factor receptors and signal transduction mechanisms. Pharmacol Rev 45:455–497
Becker JR, Chatterjee S, Robinson TY, Bennett JS, Panakova D, Galindo CL, Zhong L, Shin JT, Coy SM, Kelly AE, Roden DM, Lim CC, MacRae CA (2014) Differential activation of natriuretic peptide receptors modulates cardiomyocyte proliferation during development. Development 141:335–345. doi:10.1242/dev.100370
Bruel A, Nyengaard JR (2005) Design-based stereological estimation of the total number of cardiac myocytes in histological sections. Basic Res Cardiol 100:311–319. doi:10.1007/s00395-005-0524-9
Cameron VA, Ellmers LJ (2003) Minireview: natriuretic peptides during development of the fetal heart and circulation. Endocrinology 144:2191–2194. doi:10.1210/en.2003-0127
Cameron VA, Aitken GD, Ellmers LJ, Kennedy MA, Espiner EA (1996) The sites of gene expression of atrial, brain, and C-type natriuretic peptides in mouse fetal development: temporal changes in embryos and placenta. Endocrinology 137:817–824. doi:10.1210/endo.137.3.8603590
Charng MJ, Frenkel PA, Lin Q, Yamada M, Schwartz RJ, Olson EN, Overbeek P, Schneider MD (1998) A constitutive mutation of ALK5 disrupts cardiac looping and morphogenesis in mice. Dev Biol 199:72–79
Cheung CY (1995) Regulation of atrial natriuretic factor secretion and expression in the ovine fetus. Neurosci Biobehav Rev 19:159–164
Cheung CY, Gibbs DM, Brace RA (1987) Atrial natriuretic factor in maternal and fetal sheep. Am J Physiol 252:E279–E282
de Bold AJ, Ma KK, Zhang Y, de Bold ML, Bensimon M, Khoshbaten A (2001) The physiological and pathophysiological modulation of the endocrine function of the heart. Can J Physiol Pharmacol 79:705–714
Deloof S, Chatelain A (1994) Effect of blood volume expansion on basal plasma atrial natriuretic factor and adrenocorticotropic hormone secretions in the fetal rat at term. Biol Neonate 65:390–395
Eisele JC, Schaefer IM, Randel NJ, Post H, Liebetanz D, Bruel A, Muhlfeld C (2008) Effect of voluntary exercise on number and volume of cardiomyocytes and their mitochondria in the mouse left ventricle. Basic Res Cardiol 103:12–21. doi:10.1007/s00395-007-0684-x
Fernandez E, Siddiquee Z, Shohet RV (2001) Apoptosis and proliferation in the neonatal murine heart. Dev Dyn 221:302–310. doi:10.1002/dvdy.1139
Garbers DL (1992) Guanylyl cyclase receptors and their endocrine, paracrine, and autocrine ligands. Cell 71:1–4
Gerdes AM, Moore JA, Hines JM, Kirkland PA, Bishop SP (1986) Regional differences in myocyte size in normal rat heart. Anat Rec 215:420–426. doi:10.1002/ar.1092150414
Giraud GD, Louey S, Jonker S, Schultz J, Thornburg KL (2006) Cortisol stimulates cell cycle activity in the cardiomyocyte of the sheep fetus. Endocrinology 147:3643–3649. doi:10.1210/en.2006-0061
Gruber C, Kohlstedt K, Loot AE, Fleming I, Kummer W, Muhlfeld C (2012a) Stereological characterization of left ventricular cardiomyocytes, capillaries, and innervation in the nondiabetic, obese mouse. Cardiovasc Pathol 21:346–354. doi:10.1016/j.carpath.2011.11.003
Gruber C, Nink N, Nikam S, Magdowski G, Kripp G, Voswinckel R, Muhlfeld C (2012b) Myocardial remodelling in left ventricular atrophy induced by caloric restriction. J Anat 220:179–185. doi:10.1111/j.1469-7580.2011.01453.x
Hersey RM, Nazir MA, Whitney KD, Klein RM, Sale RD, Hinton DA, Weisz J, Gattone VH (1989) Atrial natriuretic peptide in heart and specific binding in organs from fetal and newborn rats. Cell Biochem Funct 7:35–41. doi:10.1002/cbf.290070107
Holtwick R, Gotthardt M, Skryabin B, Steinmetz M, Potthast R, Zetsche B, Hammer RE, Herz J, Kuhn M (2002) Smooth muscle-selective deletion of guanylyl cyclase-A prevents the acute but not chronic effects of ANP on blood pressure. Proc Natl Acad Sci USA 99:7142–7147. doi:10.1073/pnas.102650499
Holtwick R, van EM, Skryabin BV, Baba HA, Bubikat A, Begrow F, Schneider MD, Garbers DL, Kuhn M (2003) Pressure-independent cardiac hypertrophy in mice with cardiomyocyte-restricted inactivation of the atrial natriuretic peptide receptor guanylyl cyclase-A. J Clin Invest 111:1399–1407. doi:10.1172/JCI17061
James TN (1998) Normal and abnormal consequences of apoptosis in the human heart. Annu Rev Physiol 60:309–325. doi:10.1146/annurev.physiol.60.1.309
Kishimoto I, Rossi K, Garbers DL (2001) A genetic model provides evidence that the receptor for atrial natriuretic peptide (guanylyl cyclase-A) inhibits cardiac ventricular myocyte hypertrophy. Proc Natl Acad Sci USA 98:2703–2706. doi:10.1073/pnas.051625598
Klaiber M, Kruse M, Volker K, Schroter J, Feil R, Freichel M, Gerling A, Feil S, Dietrich A, Londono JE, Baba HA, Abramowitz J, Birnbaumer L, Penninger JM, Pongs O, Kuhn M (2010) Novel insights into the mechanisms mediating the local antihypertrophic effects of cardiac atrial natriuretic peptide: role of cGMP-dependent protein kinase and RGS2. Basic Res Cardiol 105:583–595. doi:10.1007/s00395-010-0098-z
Knowles JW, Esposito G, Mao L, Hagaman JR, Fox JE, Smithies O, Rockman HA, Maeda N (2001) Pressure-independent enhancement of cardiac hypertrophy in natriuretic peptide receptor A-deficient mice. J Clin Invest 107:975–984. doi:10.1172/JCI11273
Kuhn M (2003) Structure, regulation, and function of mammalian membrane guanylyl cyclase receptors, with a focus on guanylyl cyclase-A. Circ Res 93:700–709. doi:10.1161/01.RES.0000094745.28948.4D
Kuhn M (2004) Molecular physiology of natriuretic peptide signalling. Basic Res Cardiol 99:76–82. doi:10.1007/s00395-004-0460-0
Kuhn M, Holtwick R, Baba HA, Perriard JC, Schmitz W, Ehler E (2002) Progressive cardiac hypertrophy and dysfunction in atrial natriuretic peptide receptor (GC-A) deficient mice. Heart 87:368–374
Lopez MJ, Wong SK, Kishimoto I, Dubois S, Mach V, Friesen J, Garbers DL, Beuve A (1995) Salt-resistant hypertension in mice lacking the guanylyl cyclase-A receptor for atrial natriuretic peptide. Nature 378:65–68. doi:10.1038/378065a0
Matsukawa N, Grzesik WJ, Takahashi N, Pandey KN, Pang S, Yamauchi M, Smithies O (1999) The natriuretic peptide clearance receptor locally modulates the physiological effects of the natriuretic peptide system. Proc Natl Acad Sci USA 96:7403–7408
Mattfeldt T, Mall G, Gharehbaghi H, Moller P (1990) Estimation of surface area and length with the orientator. J Microsc 159:301–317
Mendez J, Keys A (1961) Density and composition of mammalian muscle. Metabolism 9:184–188
Morkin E (1993) Regulation of myosin heavy chain genes in the heart. Circulation 87:1451–1460
Muhlfeld C, Ochs M (2014) Measuring structure—What’s the point in counting? Ann Anat 196:1–2. doi:10.1016/j.aanat.2013.09.002
Muhlfeld C, Singer D, Engelhardt N, Richter J, Schmiedl A (2005) Electron microscopy and microcalorimetry of the postnatal rat heart (Rattus norvegicus). Comp Biochem Physiol A Mol Integr Physiol 141:310–318. doi:10.1016/j.cbpb.2005.06.001
Muhlfeld C, Nyengaard JR, Mayhew TM (2010) A review of state-of-the-art stereology for better quantitative 3D morphology in cardiac research. Cardiovasc Pathol 19:65–82. doi:10.1016/j.carpath.2008.10.015
Nyengaard JR, Gundersen HJ (1992) The isector: a simple and direct method for generating isotropic, uniform random sections from small specimens. J Microsc 165:427–431. doi:10.1111/j.1365-2818.1992.tb01497.x
Oliver PM, Fox JE, Kim R, Rockman HA, Kim HS, Reddick RL, Pandey KN, Milgram SL, Smithies O, Maeda N (1997) Hypertension, cardiac hypertrophy, and sudden death in mice lacking natriuretic peptide receptor A. Proc Natl Acad Sci USA 94:14730–14735
O’Tierney PF, Chattergoon NN, Louey S, Giraud GD, Thornburg KL (2010) Atrial natriuretic peptide inhibits angiotensin II-stimulated proliferation in fetal cardiomyocytes. J Physiol 588:2879–2889. doi:10.1113/jphysiol.2010.191098
Pandey KN (2008) Emerging roles of natriuretic peptides and their receptors in pathophysiology of hypertension and cardiovascular regulation. J Am Soc Hypertens 2:210–226. doi:10.1016/j.jash.2008.02.001
Pandey KN (2011) Guanylyl cyclase/atrial natriuretic peptide receptor-A: role in the pathophysiology of cardiovascular regulation. Can J Physiol Pharmacol 89:557–573. doi:10.1139/y11-054
Pandey KN, Singh S (1990) Molecular cloning and expression of murine guanylate cyclase/atrial natriuretic factor receptor cDNA. J Biol Chem 265:12342–12348
Rosenfeld CR, Samson WK, Roy TA, Faucher DJ, Magness RR (1992) Vasoconstrictor-induced secretion of ANP in fetal sheep. Am J Physiol 263:E526–E533
Rosenzweig A, Seidman CE (1991) Atrial natriuretic factor and related peptide hormones. Annu Rev Biochem 60:229–255. doi:10.1146/annurev.bi.60.070191.001305
Rubattu S, Sciarretta S, Morriello A, Calvieri C, Battistoni A, Volpe M (2010) NPR-C: a component of the natriuretic peptide family with implications in human diseases. J Mol Med (Berl) 88:889–897. doi:10.1007/s00109-010-0641-2
Shesely EG, Maeda N, Kim HS, Desai KM, Krege JH, Laubach VE, Sherman PA, Sessa WC, Smithies O (1996) Elevated blood pressures in mice lacking endothelial nitric oxide synthase. Proc Natl Acad Sci USA 93:13176–13181
Shi SJ, Nguyen HT, Sharma GD, Navar LG, Pandey KN (2001) Genetic disruption of atrial natriuretic peptide receptor-A alters renin and angiotensin II levels. Am J Physiol Renal Physiol 281:F665–F673
Skryabin BV, Holtwick R, Fabritz L, Kruse MN, Veltrup I, Stypmann J, Kirchhof P, Sabrane K, Bubikat A, Voss M, Kuhn M (2004) Hypervolemic hypertension in mice with systemic inactivation of the (floxed) guanylyl cyclase-A gene by alphaMHC-Cre-mediated recombination. Genesis 39:288–298. doi:10.1002/gene.20056
Sterio DC (1984) The unbiased estimation of number and sizes of arbitrary particles using the disector. J Microsc 134:127–136
Sundgren NC, Giraud GD, Stork PJ, Maylie JG, Thornburg KL (2003) Angiotensin II stimulates hyperplasia but not hypertrophy in immature ovine cardiomyocytes. J Physiol 548:881–891. doi:10.1113/jphysiol.2003.038778
Takahashi T, Allen PD, Izumo S (1992) Expression of A-, B-, and C-type natriuretic peptide genes in failing and developing human ventricles. Correlation with expression of the Ca(2+)-ATPase gene. Circ Res 71:9–17
Thornburg K, Jonker S, O’Tierney P, Chattergoon N, Louey S, Faber J, Giraud G (2011) Regulation of the cardiomyocyte population in the developing heart. Prog Biophys Mol Biol 106:289–299. doi:10.1016/j.pbiomolbio.2010.11.010
Weibel ER (1979) Stereological methods. Vol I: Practical methods for biological morphometry. Academic Press, London
Wu CF, Bishopric NH, Pratt RE (1997) Atrial natriuretic peptide induces apoptosis in neonatal rat cardiac myocytes. J Biol Chem 272:14860–14866
Acknowledgments
The authors wish to thank Susanne Kuhlmann, Christa Lichtenberg and Katharina Völker for expert technical assistance with the preparation of hearts and microscopic sections. This study was supported by the DFG via the excellence cluster REBIRTH (to CM), by the Bundesministerium für Bildung und Forschung (BMBF 01 EO1004) and the DFG (SFB 688) (to MK).
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical standard
All animal experiments were carried out according to the Guide for the Care and Use of Laboratory Animals published by the National Institutes of Health and were approved by the local animal care committee.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Schipke, J., Roloff, K., Kuhn, M. et al. Systemic, but not cardiomyocyte-specific, deletion of the natriuretic peptide receptor guanylyl cyclase A increases cardiomyocyte number in neonatal mice. Histochem Cell Biol 144, 365–375 (2015). https://doi.org/10.1007/s00418-015-1337-z
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00418-015-1337-z